Business
Precision Genomics Successfully Attends the LD Micro Conference
Precision Genomics Successfully Attends the LD Micro Conference.
About this update from Ludwig Enterprises, Inc.
[{"type":"text","content":"Dr. Hausman has been continually requested for interviews.LAS VEGAS, NV / ACCESSWIRE / November 7, 2022 / (OTC PINK:LUDG) Ludwig Enterprises with Precision Genomics, a wholly-owned subsidiary of Ludwig Enterprises, is pleased to announce our recent attendance at the LD Micro Conference was a success. LD Micro Conference is the premier event where investment banks, family offices, and the world's micro-cap companies meet for a week. The conference was attended for Precision Genomics by Dr. Marvin S. Hausman MD. Dr. Hausman was immediately recognized at the conference due to his extensive research and entrepreneurial experience, including taking two medical bio or technology companies to NASDAQ and the New York Stock exchange. Although the company showed up at the last minute, it was able to get one-on-one meetings with all the major investment Banks in attendance, which showed significant interest in what Dr. Hausman is now up to. It was a big success.Precision Genomics is a leading provider of genomic testing and analysis services. We attended the LD Micro Conference to meet with potential investors and partners. The conference was a big success thanks to our attendance and participation.Dr. Hausman's experience taking two medical bio or technology companies to NASDAQ and the New York Stock Exchange made him an immediate authority at the conference. His work with Precision Genomics has caught the eye of significant investment banks interested in meeting with him one-on-one to discuss our work. We are confident that these meetings will lead to many future opportunities for Precision Genomics.Precision Genomics and Ludwig Status UpdatePrecision Genomics, a Ludwig subsidiary, is an innovative company whose mission is to help people live longer, healthier lives. The company is working diligently to prepare and file an S-1 with the SEC, with the ultimate goal of achieving a listing on NASDAQ. A patent has been filed while the company's research program continues in the hope of delivering potentially life-saving information straight into customers' hands.Dr. Hausman - Multiple Interviews with Ground Breaking Medical NewsDr. Marvin S. Hausman MD was requested before the event and during the LD Micro conference to do interviews after the company's groundbreaking news announcement about Precision Genomics research into possible diagnosis...